The University of Texas at San Antonio (UTSA) has secured a substantial $6.8 million grant from the National Institutes of Health (NIH) to establish a Coccidioidomycosis Collaborative Research Center (SA-CCRC). Led by Chiung-Yu Hung, an associate professor in the Department of Molecular Microbiology and Immunology, the center will focus on developing therapeutics and vaccines against valley fever, also known as coccidioidomycosis. This respiratory fungal infection is prevalent in the Southwestern United States and certain regions in Central and South America, with an estimated 380,000 new cases reported annually in the U.S.
The SA-CCRC aims to address the urgent need for effective treatments and preventive measures against coccidioidomycosis, a disease that can range from mild flu-like symptoms to severe, life-threatening conditions such as meningitis. The interdisciplinary research hub will facilitate collaboration between researchers at UTSA and UT Health San Antonio, fostering innovative solutions for vaccine development and therapeutic interventions. With a focus on applied clinical research, the center will also engage experts and collaborators from various institutions nationwide, enhancing the collective knowledge and expertise in medical mycology.
Dr. Hung, a renowned expert inCoccidioidesresearch, will lead a team of researchers dedicated to developing a human vaccine utilizing recombinant antigen and mRNA technologies. This initiative aligns with the growing demand for novel therapeutic drugs and vaccines to combat fungal infections like coccidioidomycosis, especially in cases where standard antifungal treatments may be ineffective due to resistance. The center’s collaborative approach, involving seasoned investigators and emerging researchers, underscores UTSA’s commitment to addressing real-world challenges and advancing critical research in the field of mycology.
The establishment of the SA-CCRC not only signifies a significant milestone in fungal research but also highlights San Antonio’s rich tradition of excellence in studying fungal infections. With a strong emphasis on research, treatment, and training the next generation of scientists, the center aims to make substantial contributions to the understanding and management of coccidioidomycosis. By leveraging the expertise of faculty members from UTSA, UT Health San Antonio, and other partnering institutions, the center is poised to drive innovation and foster collaboration in the fight against fungal pathogens.
The involvement of key researchers such as Jose Lopez-Ribot and Thomas F. Patterson underscores the depth of talent and experience within the SA-CCRC. Leveraging their expertise in medical mycology and infectious diseases, the center is well-positioned to advance research efforts, develop new treatment modalities, and address the evolving challenges posed by fungal pathogens. The collaborative nature of the center, which includes experts from diverse fields such as molecular biology, immunology, and clinical research, reflects a holistic approach to tackling complex infectious diseases like coccidioidomycosis.
In conclusion, the NIH funding received by UTSA to establish the SA-CCRC represents a significant investment in advancing fungal research and addressing the unmet medical needs associated with coccidioidomycosis. By fostering collaboration, innovation, and knowledge exchange, the center is poised to make meaningful contributions to the development of therapeutics and vaccines against valley fever. As the SA-CCRC embarks on its research initiatives, it holds the promise of enhancing our understanding of fungal infections and paving the way for improved treatment strategies in the future.
- The $6.8 million NIH grant will support the establishment of the Coccidioidomycosis Collaborative Research Center at UTSA.
- Led by Dr. Chiung-Yu Hung, the center will focus on developing therapeutics and vaccines against valley fever.
- The interdisciplinary research hub will facilitate collaboration between researchers at UTSA and UT Health San Antonio, addressing the urgent need for effective treatments for coccidioidomycosis.
- The center’s collaborative approach, involving seasoned investigators and emerging researchers, underscores UTSA’s commitment to addressing real-world challenges in mycology research.
Read more on utsa.edu